30% off. Use code SUMMERSALE30 at checkout for 30% off for 12 months on Plus, Pro and Premium subscriptions. Subscribe now

Denny Ausiello

Track

Insider profile

Currently holds positions in Alnylam Pharmaceuticals Inc and Seres Therapeutics Inc

Positions

Position Company Period
Independent Director Alnylam Pharmaceuticals Inc April 20, 2012 -
Independent Director Seres Therapeutics Inc April 1, 2015 -
Lead Independent Director Pfizer Inc April 1, 2015 - Jan. 1, 2018
Independent Director Pfizer Inc Dec. 1, 2006 - April 1, 2015
Denny Ausiello's trades of Alnylam Pharmaceuticals Inc's stock


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Activity signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2025-08-15 2025-08-14
PlS Planned sale
9,543 +1.1%
117.41
US$3,361,517 		9,543 +1.1% 117.41 US$3,361,517
2025-08-15 2025-08-14
PlS Planned sale
39,140 -26.4%
484.99
US$2,816,293 		39,140 -26.4% 484.99 US$2,816,293
2025-08-15 2025-08-14
PlS Planned sale
68,617 +2.4%
469.65
US$578,131 		68,617 +2.4% 469.65 US$578,131
2025-08-15 2025-08-14
PlS Planned sale
5,302 -57.0%
439.27
US$2,329,010 		5,302 -57.0% 439.27 US$2,329,010
2025-08-15 2025-08-14
PlS Planned sale
2,086 -18.3%
438.34
US$914,377 		2,086 -18.3% 438.34 US$914,377
2025-08-15 2025-08-14
PlS Planned sale
1,922 -14.4%
437.56
US$840,990 		1,922 -14.4% 437.56 US$840,990
2025-08-15 2025-08-14
PlS Planned sale
5,358 -28.7%
436.00
US$2,336,088 		5,358 -28.7% 436.00 US$2,336,088
2025-08-15 2025-08-14
PlS Planned sale
7,675 -29.1%
435.40
US$3,341,695 		7,675 -29.1% 435.40 US$3,341,695
2025-08-15 2025-08-14
PlS Planned sale
2,098 -7.4%
434.50
US$911,581 		2,098 -7.4% 434.50 US$911,581
2025-08-15 2025-08-14
PlS Planned sale
1,938 -6.4%
432.94
US$839,038 		1,938 -6.4% 432.94 US$839,038
2025-08-15 2025-08-14
PlS Planned sale
1,985 -6.1%
430.81
US$855,158 		1,985 -6.1% 430.81 US$855,158
2025-08-14 2025-08-14
PrS Proposed sale
31,448
433.59
US$13,635,538 		31,448 433.59 US$13,635,538
2024-08-08 2024-08-06
PlS Planned sale
262 -65.8%
266.45
US$69,810 		262 -65.8% 266.45 US$69,810
2024-08-08 2024-08-06
PlS Planned sale
632 -61.4%
264.95
US$167,448 		632 -61.4% 264.95 US$167,448
2024-08-08 2024-08-06
PlS Planned sale
3,408 -76.8%
263.72
US$898,758 		3,408 -76.8% 263.72 US$898,758
2024-08-08 2024-08-06
PlS Planned sale
4,367 -49.6%
262.79
US$1,147,604 		4,367 -49.6% 262.79 US$1,147,604
2024-08-08 2024-08-06
PlS Planned sale
6,212 -41.4%
261.63
US$1,625,246 		6,212 -41.4% 261.63 US$1,625,246
2024-08-08 2024-08-06
PlS Planned sale
3,742 -19.9%
260.40
US$974,417 		3,742 -19.9% 260.40 US$974,417
2024-08-08 2024-08-06
PlS Planned sale
1,627 -8.0%
259.56
US$422,304 		1,627 -8.0% 259.56 US$422,304
2024-08-06 2024-08-06
PrS Proposed sale
20,250
266.66
US$5,399,865 		20,250 266.66 US$5,399,865
2022-11-23 2022-11-21
PlS Planned sale
22,500 -100.0%
220.00
US$4,950,000 		22,500 -100.0% 220.00 US$4,950,000